Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100

Haleon PLC Sponsored ADR (HLN) Book value per share

Alert me on Book value per share

Haleon PLC Sponsored ADR's book value per share at the end of fiscal 2025 was 4.8×, up 6.60% from 4.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 0.0×. Over the past ten years it has ranged from 4.4× (fiscal 2022) to 7.8× (fiscal 2019); the current reading is higher than 57% of that period. Haleon PLC Sponsored ADR ranks 58th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 4.8× 6.60%
FY2024 4.5× 0.73%
FY2023 4.5× 2.25%
FY2022 4.4× (42.81%)
FY2021 7.7× (0.43%)
FY2020 7.7× (0.50%)
FY2019 7.8× —

Quarterly newest first

Period Book value per share Change
Jun 2026 0.0× —
Jun 2025 0.0× —
Jun 2024 0.0× —
Mar 2024 0.0× —
4 more quarters

Against its own ten years

Low 4.4× High 7.8×
Ten-year median 4.8×
Current reading's percentile 57

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on HLN